Cumberland Pharmaceuticals (CPIX) Consolidated Net Income (2016 - 2026)
Cumberland Pharmaceuticals' Consolidated Net Income history spans 15 years, with the latest figure at -$1.4 million for Q4 2025.
- On a quarterly basis, Consolidated Net Income rose 25.67% to -$1.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$2.9 million, a 55.77% increase, with the full-year FY2025 number at -$2.9 million, up 55.77% from a year prior.
- Consolidated Net Income hit -$1.4 million in Q4 2025 for Cumberland Pharmaceuticals, up from -$1.9 million in the prior quarter.
- Over the last five years, Consolidated Net Income for CPIX hit a ceiling of $1.2 million in Q1 2025 and a floor of -$6.3 million in Q4 2023.
- Historically, Consolidated Net Income has averaged -$852144.9 across 4 years, with a median of -$899213.0 in 2023.
- Biggest five-year swings in Consolidated Net Income: crashed 1204.25% in 2024 and later surged 165.61% in 2025.
- Tracing CPIX's Consolidated Net Income over 4 years: stood at $503318.0 in 2021, then plummeted by 1352.09% to -$6.3 million in 2023, then surged by 69.78% to -$1.9 million in 2024, then grew by 25.67% to -$1.4 million in 2025.
- Business Quant data shows Consolidated Net Income for CPIX at -$1.4 million in Q4 2025, -$1.9 million in Q3 2025, and -$735207.0 in Q2 2025.